MSOS News

Post date: 1 week 16 hours ago

Sign up now for the next MSOS Member Briefing webinar scheduled to be held on Thursday, July 22, 2021 from 1:00-2:00 PM ET. Register Now: https://ecri.zoom.us/webinar/register/WN_s6FpmZc2Ss6AoIIObhqrcA Short medication safety-related presentations for this webinar will include:

• Use of kits for immediate use infusions Joel Daniel PharmD, MS, CPPS Medication Safety Pharmacist Cox Health

• Specialty Pharmacy Medication Safety Challenges Jill Paslier, PharmD, CSP, FISMP Specialty Pharmacy Consultant and ISMP International Medication Safety Management Fellow

•Parenteral Nutrition Safety Issues Joe Boullata, PharmD, RPh, CNS-S, FASPEN, FACN Pharmacy Specialist Clinical Nutrition Services Hospital of the University of Pennsylvania

Post date: 1 week 1 day ago

Read this week’s newsletter free featured article on the need to adopt dihydropyrimidine dehydrogenase (DPD) enzyme deficiency screening before the administration of fluoropyrimidine chemotherapy. The article argues that although the incidence is relatively low, patients who have it are unable to metabolize these drugs and can suffer severe toxicity and even fatal adverse reactions: https://www.ismp.org/node/25779

Post date: 1 week 4 days ago

Surgery sites now have more time to participate in the ISMP Medication Safety Self Assessment for Perioperative Settings! The data submission deadline has been extended to October 1, 2021. Don’t miss this opportunity to evaluate your medication use systems, identify challenges, and document regulatory compliance. Visit www.ismp.org/node/18027 to access the assessment workbook.

Post date: 3 weeks 1 day ago

Read this week’s newsletter free featured article for analysis of a tragic error after a discontinued fentaNYL infusion was left attached to a patient. The article includes ISMP’s safe practice recommendations to prevent similar errors: https://www.ismp.org/resources/leaving-discontinued-fentanyl-infusion-at...

Post date: 1 month 5 days ago

Read this week’s newsletter free featured article for an analysis of a recent report of a medication containing D&C red #33 almost being dispensed to a patient with a red dye allergy. The article includes ISMP’s safe practice recommendations: https://www.ismp.org/resources/identifying-color-additives-regulated-dru...

Pages